Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash to Debt N/A
UNIS's Cash to Debt is ranked lower than
68% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.21 vs. UNIS: N/A )
Ranked among companies with meaningful Cash to Debt only.
UNIS' s 10-Year Cash to Debt Range
Min: 0.07  Med: 0.81 Max: N/A
Current: N/A
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Operating margin (%) -433.65
UNIS's Operating margin (%) is ranked lower than
95% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.48 vs. UNIS: -433.65 )
Ranked among companies with meaningful Operating margin (%) only.
UNIS' s 10-Year Operating margin (%) Range
Min: -2225.96  Med: -349.89 Max: -1.77
Current: -433.65
-2225.96
-1.77
Net-margin (%) -492.41
UNIS's Net-margin (%) is ranked lower than
96% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.54 vs. UNIS: -492.41 )
Ranked among companies with meaningful Net-margin (%) only.
UNIS' s 10-Year Net-margin (%) Range
Min: -2303.97  Med: -394.17 Max: -2.59
Current: -492.41
-2303.97
-2.59
ROE (%) -6391.99
UNIS's ROE (%) is ranked lower than
100% of the 182 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.29 vs. UNIS: -6391.99 )
Ranked among companies with meaningful ROE (%) only.
UNIS' s 10-Year ROE (%) Range
Min: -277.5  Med: -107.17 Max: -3.54
Current: -6391.99
-277.5
-3.54
ROA (%) -102.16
UNIS's ROA (%) is ranked lower than
94% of the 193 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.43 vs. UNIS: -102.16 )
Ranked among companies with meaningful ROA (%) only.
UNIS' s 10-Year ROA (%) Range
Min: -83.87  Med: -61.11 Max: -1.74
Current: -102.16
-83.87
-1.74
ROC (Joel Greenblatt) (%) -158.71
UNIS's ROC (Joel Greenblatt) (%) is ranked lower than
83% of the 191 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 11.56 vs. UNIS: -158.71 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
UNIS' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -156.25  Med: -98.05 Max: -7.75
Current: -158.71
-156.25
-7.75
Revenue Growth (3Y)(%) 10.90
UNIS's Revenue Growth (3Y)(%) is ranked higher than
77% of the 151 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.00 vs. UNIS: 10.90 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
UNIS' s 10-Year Revenue Growth (3Y)(%) Range
Min: -50  Med: -18.70 Max: 76.5
Current: 10.9
-50
76.5
EBITDA Growth (3Y)(%) -8.80
UNIS's EBITDA Growth (3Y)(%) is ranked lower than
81% of the 128 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.70 vs. UNIS: -8.80 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
UNIS' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -8.8  Med: 1.60 Max: 149.3
Current: -8.8
-8.8
149.3
EPS Growth (3Y)(%) -5.50
UNIS's EPS Growth (3Y)(%) is ranked lower than
71% of the 126 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.70 vs. UNIS: -5.50 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
UNIS' s 10-Year EPS Growth (3Y)(%) Range
Min: -5.5  Med: 83.20 Max: 239.1
Current: -5.5
-5.5
239.1
» UNIS's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2014

UNIS Guru Trades in Q3 2014

Jim Simons 277,940 sh (-13.10%)
» More
Q4 2014

UNIS Guru Trades in Q4 2014

Ron Baron 150,514 sh (New)
Jim Simons Sold Out
» More
Q1 2015

UNIS Guru Trades in Q1 2015

Ron Baron 701,891 sh (+366.33%)
» More
Q2 2015

UNIS Guru Trades in Q2 2015

Jim Simons 27,774 sh (New)
Ron Baron 333,477 sh (-52.49%)
» More
» Details

Insider Trades

Latest Guru Trades with UNIS

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 46.34
UNIS's P/B is ranked lower than
100% of the 178 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.91 vs. UNIS: 46.34 )
Ranked among companies with meaningful P/B only.
UNIS' s 10-Year P/B Range
Min: 3.24  Med: 6.32 Max: 133.33
Current: 46.34
3.24
133.33
P/S 9.18
UNIS's P/S is ranked lower than
84% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.67 vs. UNIS: 9.18 )
Ranked among companies with meaningful P/S only.
UNIS' s 10-Year P/S Range
Min: 9.18  Med: 36.42 Max: 86.25
Current: 9.18
9.18
86.25
EV-to-EBIT -3.89
UNIS's EV-to-EBIT is ranked lower than
206% of the 120 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.58 vs. UNIS: -3.89 )
Ranked among companies with meaningful EV-to-EBIT only.
UNIS' s 10-Year EV-to-EBIT Range
Min: -19.6  Med: -6.20 Max: -2.7
Current: -3.89
-19.6
-2.7
Days Sales Outstanding 132.10
UNIS's Days Sales Outstanding is ranked lower than
92% of the 161 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 63.01 vs. UNIS: 132.10 )
Ranked among companies with meaningful Days Sales Outstanding only.
UNIS' s 10-Year Days Sales Outstanding Range
Min: 0.71  Med: 49.72 Max: 133.99
Current: 132.1
0.71
133.99

Valuation & Return

vs
industry
vs
history
Price/Median PS Value 0.42
UNIS's Price/Median PS Value is ranked higher than
98% of the 166 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.15 vs. UNIS: 0.42 )
Ranked among companies with meaningful Price/Median PS Value only.
UNIS' s 10-Year Price/Median PS Value Range
Min: 0.38  Med: 1.16 Max: 2.17
Current: 0.42
0.38
2.17
Earnings Yield (Greenblatt) (%) -25.76
UNIS's Earnings Yield (Greenblatt) (%) is ranked lower than
95% of the 184 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.90 vs. UNIS: -25.76 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
UNIS' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: -38.52  Med: 0.00 Max: 0
Current: -25.76
-38.52
0

Analyst Estimate

Jun15 Jun16
EPS($) -0.12 0.18
EPS without NRI($) -0.12 0.18

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Traded in other countries:UNS.Australia, 4UL.Germany, UNISZ.USA,
Unilife Corporation Limited, formerly Unilife Medical Solutions Limited is an US-based medical device company focused on the design, development, manufacture and supply of a proprietary range of retractable syringes. Target customers include pharmaceutical manufacturers, suppliers of medical equipment, healthcare facilities and patients who self-administer prescription medication. Unilife is ISO 13485-certified and has FDA-registered medical device manufacturing facilities in Pennsylvania.
» More Articles for UNIS

Headlines

Articles On GuruFocus.com
Weekly CEO Buys Highlight: BH, TRCR, SHOR, IEC, UNIS Feb 10 2012 
Weekly CEO Buys Highlight: BH, TRCR, SHOR, IEC, UNIS Feb 10 2012 
Weekly CEO Buys Highlight: IDCC, MWW, UNIS Jan 29 2012 
Weekly CEO Buys Highlight: IDCC, MWW, UNIS Jan 28 2012 
Weekly CEO Buys Highlight: IDCC, MWW, UNIS Jan 28 2012 
Medical. All insider Jan 24 2012 
Weekly CEO Buys Highlight: TRNO, UNIS, GFN Jan 21 2012 
Weekly CEO Buys Highlight: UNIS, TRNO, WINA, SXC, CTFO Jan 14 2012 
3.31 Jan 12 2012 
Recent Purchase Jan 08 2012 

More From Other Websites
Unilife (UNIS) Stock Jumps After Third-Party Expresses Interest Sep 02 2015
Unilife says exploring sale after getting "expression of interest" Sep 02 2015
UNILIFE CORP Files SEC form 8-K, Other Events Sep 02 2015
Unilife Announces Review of Strategic Alternatives Sep 02 2015
Unilife Announces Review of Strategic Alternatives Sep 02 2015
9:00 am Unilife Corporation announces review of strategic alternatives in response to third-party... Sep 02 2015
UNILIFE CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Aug 31 2015
UNILIFE CORP Files SEC form 8-K, Other Events Aug 28 2015
Unilife Appoints Harry Hamill to the Board of Directors Aug 25 2015
UNILIFE CORP Files SEC form 8-K, Change in Directors or Principal Officers Aug 25 2015
Unilife Appoints Harry Hamill to the Board of Directors Aug 25 2015
UNILIFE CORP Files SEC form 8-K, Other Events Aug 19 2015
Former Employee Issues Apology and Withdraws Whistleblower Lawsuit Aug 19 2015
Unilife (UNIS) Stock Lower on Jefferies Downgrade Aug 06 2015
Unilife Corporation downgraded by Jefferies Aug 06 2015
UNILIFE CORP Files SEC form 8-K, Change in Directors or Principal Officers Jul 31 2015
UNILIFE CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Jul 30 2015
Unilife Corp Introduces World's First Instant Patch Pump for Insulin Call scheduled for 8:30 am ET... Jul 30 2015
Unilife Announces Multifaceted Financing Strategy Jul 29 2015
Unilife Announces Multifaceted Financing Strategy Jul 29 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK